Selected research
Industry Research
Antiemetics Industry Research Report 2026
Market perspective
The global Antiemetics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Antiemetics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Antiemetics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Antiemetics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Antiemetics include Johnson & Johnson, Merck, Eli Lilly, Pfizer, GlaxoSmithKline, Baxter, Sanofi Aventis, Bristol Myers Squibb and Astellas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Antiemetics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antiemetics Market by Company
Johnson & Johnson
Merck
Eli Lilly
Pfizer
GlaxoSmithKline
Baxter
Sanofi Aventis
Bristol Myers Squibb
Astellas
Antiemetics Segment by Type
Steroids
Antihistamines (H1 histamine receptor antagonists)
Anticholinergics
Dopamine antagonists
Cannabinoids
Benzodiazepines
NK1 receptor antagonist
5-HT3 receptor antagonists
Others
Antiemetics Segment by Application
Retail Pharmacy
Online Pharmacy
Hospital Pharmacy
Others
Antiemetics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiemetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antiemetics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiemetics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antiemetics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antiemetics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antiemetics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Steroids
- Antihistamines (H1 histamine receptor antagonists)
- Anticholinergics
- Dopamine antagonists
- Cannabinoids
- Benzodiazepines
- NK1 receptor antagonist
- 5-HT3 receptor antagonists
- Others
Applications
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
- Others
Companies covered
- Johnson & Johnson
- Merck
- Eli Lilly
- Pfizer
- GlaxoSmithKline
- Baxter
- Sanofi Aventis
- Bristol Myers Squibb
- Astellas
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Antiemetics Market Size (2021-2032)
- 2.2.2 Global Antiemetics Sales (2021-2032)
- 2.2.3 Global Antiemetics Market Average Price (2021-2032)
- 2.3 Antiemetics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Steroids
- 2.3.3 Antihistamines (H1 histamine receptor antagonists)
- 2.3.4 Anticholinergics
- 2.3.5 Dopamine antagonists
- 2.3.6 Cannabinoids
- 2.3.7 Benzodiazepines
- 2.3.8 NK1 receptor antagonist
- 2.3.9 5-HT3 receptor antagonists
- 2.3.10 Others
- 2.4 Antiemetics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacy
- 2.4.3 Online Pharmacy
- 2.4.4 Hospital Pharmacy
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Antiemetics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Antiemetics Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Antiemetics Revenue of Manufacturers (2021-2026)
- 3.4 Global Antiemetics Average Price by Manufacturers (2021-2026)
- 3.5 Global Antiemetics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Antiemetics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Antiemetics, Product Type & Application
- 3.8 Global Manufacturers of Antiemetics, Established Date
- 3.9 Global Antiemetics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson Antiemetics Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 Merck
- 4.2.1 Merck Company Information
- 4.2.2 Merck Business Overview
- 4.2.3 Merck Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck Antiemetics Product Portfolio
- 4.2.5 Merck Recent Developments
- 4.3 Eli Lilly
- 4.3.1 Eli Lilly Company Information
- 4.3.2 Eli Lilly Business Overview
- 4.3.3 Eli Lilly Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Eli Lilly Antiemetics Product Portfolio
- 4.3.5 Eli Lilly Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Antiemetics Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 GlaxoSmithKline
- 4.5.1 GlaxoSmithKline Company Information
- 4.5.2 GlaxoSmithKline Business Overview
- 4.5.3 GlaxoSmithKline Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 GlaxoSmithKline Antiemetics Product Portfolio
- 4.5.5 GlaxoSmithKline Recent Developments
- 4.6 Baxter
- 4.6.1 Baxter Company Information
- 4.6.2 Baxter Business Overview
- 4.6.3 Baxter Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Baxter Antiemetics Product Portfolio
- 4.6.5 Baxter Recent Developments
- 4.7 Sanofi Aventis
- 4.7.1 Sanofi Aventis Company Information
- 4.7.2 Sanofi Aventis Business Overview
- 4.7.3 Sanofi Aventis Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sanofi Aventis Antiemetics Product Portfolio
- 4.7.5 Sanofi Aventis Recent Developments
- 4.8 Bristol Myers Squibb
- 4.8.1 Bristol Myers Squibb Company Information
- 4.8.2 Bristol Myers Squibb Business Overview
- 4.8.3 Bristol Myers Squibb Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bristol Myers Squibb Antiemetics Product Portfolio
- 4.8.5 Bristol Myers Squibb Recent Developments
- 4.9 Astellas
- 4.9.1 Astellas Company Information
- 4.9.2 Astellas Business Overview
- 4.9.3 Astellas Antiemetics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Astellas Antiemetics Product Portfolio
- 4.9.5 Astellas Recent Developments
5 Global Antiemetics Market Scenario by Region
- 5.1 Global Antiemetics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Antiemetics Sales by Region: 2021-2032
- 5.2.1 Global Antiemetics Sales by Region: 2021-2026
- 5.2.2 Global Antiemetics Sales by Region: 2027-2032
- 5.3 Global Antiemetics Revenue by Region: 2021-2032
- 5.3.1 Global Antiemetics Revenue by Region: 2021-2026
- 5.3.2 Global Antiemetics Revenue by Region: 2027-2032
- 5.4 North America Antiemetics Market Facts & Figures by Country
- 5.4.1 North America Antiemetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Antiemetics Sales by Country (2021-2032)
- 5.4.3 North America Antiemetics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Antiemetics Market Facts & Figures by Country
- 5.5.1 Europe Antiemetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Antiemetics Sales by Country (2021-2032)
- 5.5.3 Europe Antiemetics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Antiemetics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Antiemetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Antiemetics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Antiemetics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Antiemetics Market Facts & Figures by Country
- 5.7.1 South America Antiemetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Antiemetics Sales by Country (2021-2032)
- 5.7.3 South America Antiemetics Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Antiemetics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Antiemetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Antiemetics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Antiemetics Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Antiemetics Sales by Type (2021-2032)
- 6.1.1 Global Antiemetics Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Antiemetics Sales Market Share by Type (2021-2032)
- 6.2 Global Antiemetics Revenue by Type (2021-2032)
- 6.2.1 Global Antiemetics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Antiemetics Revenue Market Share by Type (2021-2032)
- 6.3 Global Antiemetics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Antiemetics Sales by Application (2021-2032)
- 7.1.1 Global Antiemetics Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Antiemetics Sales Market Share by Application (2021-2032)
- 7.2 Global Antiemetics Revenue by Application (2021-2032)
- 7.2.1 Global Antiemetics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Antiemetics Revenue Market Share by Application (2021-2032)
- 7.3 Global Antiemetics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Antiemetics Value Chain Analysis
- 8.1.1 Antiemetics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Antiemetics Production Mode & Process
- 8.2 Antiemetics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Antiemetics Distributors
- 8.2.3 Antiemetics Customers
9 Global Antiemetics Analyzing Market Dynamics
- 9.1 Antiemetics Industry Trends
- 9.2 Antiemetics Industry Drivers
- 9.3 Antiemetics Industry Opportunities and Challenges
- 9.4 Antiemetics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst